05 Compliance

The regulatory file for NADH disodium

Technical document 05 · Reviewed 2026-11-20 · NADH

On this page
  1. The supplier-side file
  2. European Union
  3. United States
  4. United Kingdom
  5. Ingredient limits and the finished product
  6. Naming the ingredient and reviewing claims
  7. Documents for the NADH file
  8. Checklist before the first order

NADH disodium is supplied to a catalog specification; permission to use it is a separate question that turns on the destination. In the EU, as of this review, the novel food catalogue classifies NAD+ and NADH as not novel in food supplements and does not extend that position to other foods, so a drink or a fortified food is not covered by that listing. In the US, the DSHEA route and, for a newer ingredient, an NDI notification apply. The buyer's regulatory team owns the route, the dose and the label.

In one line

The specification covers the powder; the market entry, the dose and the label are destination questions that the buyer's regulatory team confirms.

The supplier-side file

Before any route can be chosen, the supplier side has to be in order. That means a versioned specification, a lot COA, a TDS and an SDS, plus dated allergen, GMO, origin and residual-solvent statements and a change-control record. Undated scans collected in a folder do not make a file.

The specification should identify the reduced disodium salt, CAS 606-68-8 and the assay basis; the certificate and the quotation should cite the same revision. If a statement is absent for the lot, surface it at quotation rather than at the port.

European Union

The EU file rests on five instruments: general food law (Regulation (EC) No 178/2002), food information and labelling (Regulation (EU) No 1169/2011), food supplements (Directive 2002/46/EC), contaminants (Regulation (EU) 2023/915) and, where the substance is not established, the novel food Regulation (EU) 2015/2283.

The novel food catalogue is the first place to check for NADH. As of this review it lists NAD+ and NADH as not novel in food supplements, and it does not extend that position to other foods. A supplement is therefore the category to match; a beverage, a bar or a fortified food needs its own route. The catalogue and the consolidated texts can change, so verify both before relying on this paragraph.

Any novel-food position is specific to a substance, a form, a use level and a food category. The buyer's team should record which entry it relies on and keep the evidence with the order. Framework references are collected in the EU regulatory notes.

United States

In the US, the frame is the Federal Food, Drug, and Cosmetic Act as amended by DSHEA. A dietary ingredient with a market history before 15 October 1994 can use the pre-DSHEA provision; a newer one normally needs an NDI notification under 21 CFR Part 190. Manufacturing and the Supplement Facts panel sit under 21 CFR Part 111 and 21 CFR 101.36.

Nothing on this page asserts that an NADH notification exists, or that any notification covers this salt, this dose and this market. The buyer confirms the basis and keeps the evidence on file.

United Kingdom

The UK does not run a single file. As of this review, Great Britain keeps its own novel food register and guidance, while Northern Ireland follows the EU framework described above. Which one applies depends on the delivery address; the buyer's team should record the decision with the order so that the label and the entry cited can be checked later.

Ingredient limits and the finished product

The metal limits in the catalog are written for the ingredient. The finished product needs its own calculation: the lot result multiplied by the dose, set against the destination limit.

Catalog limits and what the finished-product file shows
ParameterCatalog limitWhat the file confirms
Lead (Pb)≤3 mg/kgLot figure, method and the dose calculation
Arsenic (As)≤2 mg/kgLot figure and the destination limit
Cadmium (Cd)≤1 mg/kgLot figure and any category exception
Mercury (Hg)≤0.1 mg/kgLot figure and method
MicrobiologyAPC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absentThe plate count and the absence finding

A micro result releases the lot; it does not make the powder sterile. Keep the retained sample so a contested result can be re-examined against the named method.

Naming the ingredient and reviewing claims

This page makes no disease-related claim. The label has to name the reduced form and its salt, and any structure/function wording needs substantiation, the DSHEA disclaimer where it applies, and a market check. Energy, fatigue or cellular wording is claim language; it is not a property of the certificate.

Claim review runs beside the specification, not inside it. A certificate cannot authorise wording, and rewording a claim does not reopen the specification. The reviewer needs the finished dose, the form and the destination to hand.

Documents for the NADH file

  • Versioned specification naming the reduced disodium salt and CAS 606-68-8.
  • Lot COA with the assay wavelength and basis, loss on drying, sodium where measured, metals and micro.
  • Current TDS and SDS.
  • Allergen, GMO and origin statements.
  • Residual-solvent statement for the route used.
  • Stability summary for the pack on order.
  • Change-control record covering source, process and pack.
  • Dated regulatory position for the destination.

Every document should carry a date and a revision. Find the gaps before the order, not when the container is already booked.

Checklist before the first order

  • Form, CAS number and specification revision are named.
  • The destination route has been confirmed in writing by the buyer's regulatory team.
  • The use level and the finished dose sit inside that route.
  • The COA carries the assay wavelength, the basis and the loss on drying.
  • TDS and SDS are current.
  • Allergen, GMO, origin and residual-solvent declarations carry dates.
  • The metal results are converted to the finished-product dose.
  • The label and claims have been reviewed for the destination rules.

The NADH product page carries the catalog specification. The COA page explains the lot certificate, and the identity page covers the analytical evidence. The release file is described on the quality page, and the NAD+ page holds the oxidised form for comparison.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation